Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diuretics for Rosiglitazone-related Fluid Retention in Type 2 Diabetes
NCT00306696Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2002
- Modality
- Small Molecules
- Countries
- 14
01
Overview
Phase 4, randomised, open-label trial of spironolactone, hydrochlorothiazide and furosemide in edema (2 arms), sponsored by GSK. Primary endpoint: Changes in Haematocrit following 7 days diuretic administration. Started Oct 2002; status: completed.
02
Drugs
spironolactonehydrochlorothiazidefurosemide
03
Conditions
edema
Beyond the preview
Go deeper on NCT00306696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306696.